Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

2015 Genitourinary Cancers Symposium /
ASCO GU 2015: Review of the latest data in prostate cancer

26th - 28th Feb 2015

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 27.02.15
Views: 4882
Rating:

Prof Eleni Efstathiou, Prof Charles Ryan, Dr Heather Payne

Prof Efstathiou (MD Anderson Cancer Center, Houston, USA) chairs a discussion with Prof Ryan (University of California, San Francisco, USA), and Dr Payne (University College Hospital, London, UK) about the evolving treatment options in castration-resistant prostate cancer (CRPC) for ecancertv at ASCO GU 2015.

They discuss the latest data and topics of interest presented from this congress and its potential impact on clinical practice, contemplating the ways in which androgen resistance may be overcome and what the best sequences for newly available drugs may be. 

They also consider how patient sub-groups that can optimally benefit from new treatment approaches can be better identified and what the future may hold for the treatment of CRPC.

This programme has been supported by an unrestricted educational grant from Janssen Pharmaceutica (A Johnson & Johnson Company).

 

 

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation